Charles River Laboratories International Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones

Dec 19, 2025

DJ Charles River Laboratories International Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Charles River Laboratories International Inc. $(CRL)$ slipped 1.09% to $193.85 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.79% to 6,774.76 and the Dow Jones Industrial Average rising 0.14% to 47,951.85.

Charles River Laboratories International Inc. closed 3.36% short of its 52-week high of $200.58, which the company achieved on December 15th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Labcorp Holdings Inc. $(LH)$ fell 1.48% to $252.03, Alnylam Pharmaceuticals Inc. $(ALNY)$ rose 1.00% to $396.04, and Bio-Techne Corp. $(TECH)$ rose 0.19% to $57.10.

Trading volume (670,194) remained 326,622 below its 50-day average volume of 996,816.

Data source: Dow Jones Market Data, FactSet. Data compiled December 18, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

December 18, 2025 17:18 ET (22:18 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2592182176"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2592182176\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2592182176?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-19 06:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2592182176","market":"other","top_or_hot":-1,"title":"Charles River Laboratories International Inc. Stock Outperforms Competitors Despite Losses On The Day","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Charles River Laboratories International Inc. Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Charles River Laboratories International Inc. <a href=\"https://laohu8.com/S/CRL\">$(CRL)$</a> slipped 1.09% to $193.85 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&amp;P 500 Index  rising 0.79% to 6,774.76 and the Dow Jones Industrial Average  rising 0.14% to 47,951.85. \n</p>\n<p>\n     Charles River Laboratories International Inc. closed 3.36% short of its 52-week high of $200.58, which the company achieved on December 15th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Labcorp Holdings Inc. <a href=\"https://laohu8.com/S/LH\">$(LH)$</a> fell 1.48% to $252.03, Alnylam Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/ALNY\">$(ALNY)$</a> rose 1.00% to $396.04, and Bio-Techne Corp. <a href=\"https://laohu8.com/S/TECH\">$(TECH)$</a> rose 0.19% to $57.10. \n</p>\n<p>\n     Trading volume (670,194) remained 326,622 below its 50-day average volume of 996,816. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 18, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 18, 2025 17:18 ET (22:18 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Charles River Laboratories International Inc. Stock Outperforms Competitors Despite Losses On The Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCharles River Laboratories International Inc. Stock Outperforms Competitors Despite Losses On The Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-12-19 06:18</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Charles River Laboratories International Inc. Stock Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Charles River Laboratories International Inc. <a href=\"https://laohu8.com/S/CRL\">$(CRL)$</a> slipped 1.09% to $193.85 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&amp;P 500 Index  rising 0.79% to 6,774.76 and the Dow Jones Industrial Average  rising 0.14% to 47,951.85. \n</p>\n<p>\n     Charles River Laboratories International Inc. closed 3.36% short of its 52-week high of $200.58, which the company achieved on December 15th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Labcorp Holdings Inc. <a href=\"https://laohu8.com/S/LH\">$(LH)$</a> fell 1.48% to $252.03, Alnylam Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/ALNY\">$(ALNY)$</a> rose 1.00% to $396.04, and Bio-Techne Corp. <a href=\"https://laohu8.com/S/TECH\">$(TECH)$</a> rose 0.19% to $57.10. \n</p>\n<p>\n     Trading volume (670,194) remained 326,622 below its 50-day average volume of 996,816. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 18, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 18, 2025 17:18 ET (22:18 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CRL","symbol_name":"查尔斯河","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2592182176","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2592182176","pubTimestamp":1766096280,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Charles River Laboratories International Inc.  slipped 1.09% to $193.85 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.79% to 6,774.76 and the Dow Jones Industrial Average  rising 0.14% to 47,951.85.Charles River Laboratories International Inc. closed 3.36% short of its 52-week high of $200.58, which the company achieved on December 15th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Labcorp Holdings Inc.  fell 1.48% to $252.03, Alnylam Pharmaceuticals Inc.  rose 1.00% to $396.04, and Bio-Techne Corp.  rose 0.19% to $57.10.Trading volume  remained 326,622 below its 50-day average volume of 996,816.Data source: Dow Jones Market Data, FactSet. Data compiled December 18, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. Mark","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"CRL":"查尔斯河"},"translate_title":"尽管当天下跌，查尔斯河实验室国际公司(Charles River Laboratories International Inc.)的股票表现仍优于竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRL":1.5},"content_text":"DJ Charles River Laboratories International Inc. Stock Outperforms Competitors Despite Losses On The Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Charles River Laboratories International Inc. $(CRL)$ slipped 1.09% to $193.85 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.79% to 6,774.76 and the Dow Jones Industrial Average  rising 0.14% to 47,951.85. \n\n\n     Charles River Laboratories International Inc. closed 3.36% short of its 52-week high of $200.58, which the company achieved on December 15th. \n\n\n     The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Labcorp Holdings Inc. $(LH)$ fell 1.48% to $252.03, Alnylam Pharmaceuticals Inc. $(ALNY)$ rose 1.00% to $396.04, and Bio-Techne Corp. $(TECH)$ rose 0.19% to $57.10. \n\n\n     Trading volume (670,194) remained 326,622 below its 50-day average volume of 996,816. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 18, 2025. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 18, 2025 17:18 ET (22:18 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}